Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-
40% of colorectal cancer patients. The hallmarks of systemic inflammation include an …

OBJECTIVE: Fecal immunochemical tests (FITs) detect the majority of colorectal cancers
(CRCs), but evidence for variation in sensitivity according to the CRC stage is sparse and …

Fructose consumption is linked to the rising incidence of obesity and cancer, which are two
of the leading causes of morbidity and mortality globally,. Dietary fructose metabolism …

Unravel the regulatory mechanism of lncRNA CCDC144NL-AS1 in CRC hsa-miR-143-3p,
downstream protein HMGA2 interaction arm, association with clinicopathological …

Despite complete resection, cancer recurrence frequently occurs in clinical practice. This
indicates that cancer cells had already metastasized from their organ of origin at the time of …

Background Although high T cell density is a strong favourable prognostic factor in
colorectal cancer, the significance of the spatial distribution of T cells is incompletely …

Background The aim of this study was to evaluate whether sarcopenia or myosteatosis have
an impact on short-and long-term results in patients who were surgically treated for …

Background Cancer cachexia is a complex wasting syndrome affecting patients with
advanced cancer, with systemic inflammation as a key component in pathogenesis. Protein …

PURPOSE Globally, colorectal cancer (CRC) ranks third in terms of incidence and second in
terms of mortality. A relatively low burden of CRC has been reported from low-and middle …

Background Early detection of colorectal cancer (CRC) improves prognosis, yet many CRCs
are diagnosed following symptoms. The aim of this study was to determine which CRC …